RNA Nanotechnology-Mediated Cancer Immunotherapy

被引：113

作者：

Lin, Yao-Xin ^{[1
,2
]}

Wang, Yi ^{[1
,2
,3
,5
]}

Blake, Sara ^{[1
,2
,6
]}

Yu, Mian ^{[4
]}

Mei, Lin ^{[4
]}

Wang, Hao ^{[3
,5
]}

Shi, Jinjun ^{[1
,2
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Ctr Nanomed, Boston, MA 02115 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA

[3] Natl Ctr Nanosci & Technol, CAS Key Lab Biomed Effects Nanomat & Nanosafety, CAS Ctr Excellence Nanosci, Beijing 100190, Peoples R China

[4] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510006, Guangdong, Peoples R China

[5] Univ Chinese Acad Sci, Ctr Mat Sci & Optoelect Engn, Beijing 100049, Peoples R China

[6] Tufts Univ, Medford, MA 02155 USA

来源：

THERANOSTICS | 2020年 / 10卷 / 01期

基金：

中国博士后科学基金;

关键词：

RNA; nanoparticle; immunotherapy; cancer; RNAi; CRISPR; SMALL-INTERFERING RNA; SENSITIVE POLYMERIC NANOPARTICLES; MESOPOROUS SILICA NANOPARTICLES; TUMOR-ASSOCIATED MACROPHAGES; LIPID-BASED NANOPARTICLES; DRUG-DELIVERY SYSTEMS; REGULATORY T-CELLS; MESSENGER-RNA; DENDRITIC CELLS; SIRNA DELIVERY;

D O I：

10.7150/thno.35568

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

RNA molecules (e.g., siRNA, microRNA, and mRNA) have shown tremendous potential for immunomodulation and cancer immunotherapy. They can activate both innate and adaptive immune system responses by silencing or upregulating immune-relevant genes. In addition, mRNA-based vaccines have recently been actively pursued and tested in cancer patients, as a form of treatment. Meanwhile, various nanomaterials have been developed to enhance RNA delivery to the tumor and immune cells. In this review article, we summarize recent advances in the development of RNA-based therapeutics and their applications in cancer immunotherapy. We also highlight the variety of nanoparticle platforms that have been used for RNA delivery to elicit anti-tumor immune responses. Finally, we provide our perspectives of potential challenges and opportunities of RNA-based nanotherapeutics in clinical translation towards cancer immunotherapy.

引用

页码：281 / 299

页数：19

共 50 条

[21] Nanotechnology in the arena of cancer immunotherapy
Md. Asadujjaman
Kwan Hyung Cho
Dong-Jin Jang
Joo-Eun Kim
Jun-Pil Jee
Archives of Pharmacal Research, 2020, 43 : 58 - 79
[22] Nanotechnology platforms for cancer immunotherapy
Yang, Zhaogang
Ma, Yifan
Zhao, Hai
Yuan, Yuan
Kim, Betty Y. S.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2020, 12 (02)
[23] Nanotechnology in the arena of cancer immunotherapy
Asadujjaman, Md.
Cho, Kwan Hyung
Jang, Dong-Jin
Kim, Joo-Eun
Jee, Jun-Pil
ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (01) : 58 - 79
[24] The application of nanotechnology in cancer immunotherapy
Szymanowski, Wojciech
Gornowicz, Agnieszka
Bielawska, Anna
Bielawski, Krzysztof
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2020, 74 : 131 - 143
[25] Nanotechnology-mediated delivery of resveratrol as promising strategy to improve therapeutic efficacy in triple negative breast cancer (TNBC): progress and promises
Ahmad, Javed
Ahamad, Javed
Algahtani, Mohammed S.
Garg, Anuj
Shahzad, Naiyer
Ahmad, Mohammad Zaki
Imam, Syed Sarim
EXPERT OPINION ON DRUG DELIVERY, 2024, 21 (02) : 229 - 244
[26] Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti-tumor Effects
Yu, Mian
Zhao, Miaoqing
Yu, Rilei
Chu, Shaochen
Xu, Jiahao
Xia, Ming
Wang, Cheng
JOURNAL OF CONTROLLED RELEASE, 2019, 304 : 242 - 258
[27] Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review
Kulkarni, Abhijeet D.
Vanjari, Yogesh H.
Sancheti, Karan H.
Belgamwar, Veena S.
Surana, Sanjay J.
Pardeshi, Chandrakantsing V.
JOURNAL OF DRUG TARGETING, 2015, 23 (09) : 775 - 788
[28] Nanotechnology-mediated developments for improving physicochemical properties and wound healing efficacy of curcumin: a review
Naseem, Mahnoor Ahmed
Hussain, Zahid
Thu, Hnin Ei
Khan, Shahzeb
Sohail, Mohammad
Sarfraz, Rai Muhammad
Mahmood, Asif
INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2025, 74 (05) : 445 - 464
[29] Nanotechnology-mediated therapeutic strategies against synucleinopathies in neurodegenerative disease (vol 31, 100673 2021)
Schlichtmann, Benjamin W.
Hepker, Monica
Palanisamy, Bharathi N.
John, Manohar
Anantharam, Vellareddy
Kanthasamy, Anumantha G.
Narasimhan, Balaji
Mallapragada, Surya K.
CURRENT OPINION IN CHEMICAL ENGINEERING, 2021, 34
[30] Zebrafish: A Promising Real-Time Model System for Nanotechnology-Mediated Neurospecific Drug Delivery
Suraiya Saleem
Rajaretinam Rajesh Kannan
Nanoscale Research Letters, 16

← 1 2 3 4 5 →